dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Veillon, Remi |
dc.contributor.author | Sakai, Hiroshi |
dc.contributor.author | Felip Font, Enriqueta |
dc.contributor.author | Cortot, Alexis |
dc.contributor.author | Le, Xiuning |
dc.contributor.author | Smit, Egbert |
dc.date.accessioned | 2022-09-09T07:16:34Z |
dc.date.available | 2022-09-09T07:16:34Z |
dc.date.issued | 2022-06 |
dc.identifier.citation | Veillon R, Sakai H, Le X, Felip E, Cortot AB, Smit EF, et al. Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management. Clin Lung Cancer. 2022 Jun;23(4):320–32. |
dc.identifier.issn | 1525-7304 |
dc.identifier.uri | https://hdl.handle.net/11351/8083 |
dc.description | Edema; Nàusees; Càncer de pulmó de cèl·lules no petites |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Clinical Lung Cancer;23(4) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Pulmons - Càncer - Tractament |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject.mesh | Carcinoma, Non-Small-Cell Lung |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Treatment Outcome |
dc.title | Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.cllc.2022.03.002 |
dc.subject.decs | carcinoma de pulmón de células no pequeñas |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | resultado del tratamiento |
dc.relation.publishversion | https://doi.org/10.1016/j.cllc.2022.03.002 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Veillon R] CHU Bordeaux, Service des Maladies Respiratoires, Bordeaux, France. [Sakai H] Department of Thoracic Oncology, Saitama Cancer Center, Saitama, Japan. [Le X] Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. [Felip E] Department of Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Cortot AB] Univ. Lille, CHU Lille, CNRS, Inserm, Institut Pasteur de Lille, UMR9020 – UMR-S 1277 - Canther, Lille, France. [Smit EF] Netherlands Cancer Institute, Amsterdam, The Netherlands |
dc.identifier.pmid | 35466070 |
dc.identifier.wos | 000810868000011 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |